Physician profile
Rodney V Harrison
NPI 1962448712
$14,437.50
in general payments reported to CMS, 2019-2025
42 companies · $2,472 in 2025
The $2,472 reported for 2025 was more than what 90% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $958 · 2021: $1,948 · 2022: $2,507 · 2023: $2,846 · 2024: $2,949 · 2025: $2,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,266.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,375.24 | 2019-2025 | |
| Amgen INC. | $1,262.53 | 2020-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,047.22 | 2020-2025 | Jot Dx, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $987.42 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $977.71 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $915.32 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $868.61 | 2019-2025 | Watchman Flx, Watchman Access System, Cds - Mct/Cem Monitoring |
| Astrazeneca Pharmaceuticals LP | $726.11 | 2020-2025 | Farxiga, Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $621.34 | 2022-2025 | Verquvo |
| Pfizer INC. | $581.15 | 2021-2025 | |
| Philips North America LLC | $563.59 | 2023-2025 | (Ck4) Mcot, Event, Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $525.40 | 2020-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $432.95 | 2022-2025 | Onpattro |
| Esperion Therapeutics, INC. | $287.90 | 2020-2025 | Nexletol |
| Scpharmaceuticals INC. | $241.98 | 2023-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.